Legislation

Cigar Industry Argues For Relief From Key Product Approval Deadline

Mar 18, 2020 | By Andrew Nagy
Cigar Industry Argues For Relief From Key Product Approval Deadline

As an important product approval deadline looms, the cigar industry asked a trio of circuit court judges this morning for relief.

Last July, Judge Paul Grimm of the U.S. District Court for the District of Maryland ruled against the FDA’s decision to extend the Substantial Equivalence deadline to 2021, shortening it instead to May 12, 2020.

Substantial Equivalence is one of the three pathways to product approval that the FDA outlined in its Final Deeming Rule of 2016. It allows a cigar manufacturer to file a report showing that a new tobacco product has similar characteristics to a grandfathered (or predicate) tobacco product, or has different characteristics, but doesn't raise any new questions of public health. A predicate tobacco product is one that was on the market on February 15, 2007.

In response to Judge Grimm’s ruling, the three main cigar lobbying groups—Cigar Association of America, Cigar Rights of America and the Premium Cigar Association—filed a motion to intervene, hoping to push the date back to 2021.

This morning, attorney Mark Raffman argued for the cigar industry in front of Judges G. Steven Agee, Stephanie D. Thacker and Allison J. Rushing, of the U.S. Court of Appeals for the Fourth Circuit. The oral arguments were given via video conference due to the Coronavirus outbreak.

The crux of the cigar industry’s case is that when Judge Grimm offered his decision last July, he believed that he was primarily trying to help put an end to the youth vaping epidemic. At one point, the judges asked about a series of regulations the FDA is considering applying to flavored cigars.

“Flavored cigars are not 50 percent of the market, and two of our associations don’t make those cigars,” argued Raffman, “and those two associations are the ones who are going to bear the great burden of this order because they make the largest number stock-keeping units (SKUs), they’re FDA’s lowest priority and yet they’re the ones who are going to have to spend millions of dollars for the May 2020 deadline that the agency doesn’t even think is appropriate for those cigars.”

In his final remarks, Judge Agee said that he understood that the case was time sensitive and hoped to have a decision as soon as possible.

FDA

More in Legislation

See all
Florida Representatives Urge President to Drop Cigar Industry Regulations

Florida Representatives Urge President to Drop Cigar Industry Regulations

In response to the economic downturn, a dozen representatives from Florida have signed and sent a …

Jun 8, 2020
Court Ruling Ends Chances of 2021 Deadline for FDA Product Reports

Court Ruling Ends Chances of 2021 Deadline for FDA Product Reports

The FDA’s pre-market application deadline for cigars will remain September 9 after a trio of judges …

May 5, 2020
Judge Extends Deadline for FDA Product Approval Reports

Judge Extends Deadline for FDA Product Approval Reports

Cigar manufacturers received a bit of good news last week as the FDA’s premarket application deadline …

Apr 28, 2020
New York State Raising Cigar Taxes This Fall

New York State Raising Cigar Taxes This Fall

New York state lawmakers passed a $177 billion budget for 2021 that includes a tax rate of 75 percent …

Apr 15, 2020
FDA Asks Court for Extension of Key Product Deadline Due to Coronavirus Outbreak

FDA Asks Court for Extension of Key Product Deadline Due to Coronavirus Outbreak

The U.S. Food and Drug Administration filed a motion in court requesting a 120-day extension of the …

Mar 31, 2020
Cigar Industry Petitions for Six-Month Delay from Upcoming Substantial Equivalence Deadline

Cigar Industry Petitions for Six-Month Delay from Upcoming Substantial Equivalence Deadline

Due to the impact of the Coronavirus pandemic, leading lobbying groups for the handmade cigar …

Mar 24, 2020